Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383551209> ?p ?o ?g. }
- W4383551209 endingPage "720" @default.
- W4383551209 startingPage "706" @default.
- W4383551209 abstract "Pre-clinical models demonstrate that platelet activation is involved in the spread of malignancy. Ongoing clinical trials are assessing whether aspirin, which inhibits platelet activation, can prevent or delay metastases.Urinary 11-dehydro-thromboxane B2 (U-TXM), a biomarker of in vivo platelet activation, was measured after radical cancer therapy and correlated with patient demographics, tumour type, recent treatment, and aspirin use (100 mg, 300 mg or placebo daily) using multivariable linear regression models with log-transformed values.In total, 716 patients (breast 260, colorectal 192, gastro-oesophageal 53, prostate 211) median age 61 years, 50% male were studied. Baseline median U-TXM were breast 782; colorectal 1060; gastro-oesophageal 1675 and prostate 826 pg/mg creatinine; higher than healthy individuals (~500 pg/mg creatinine). Higher levels were associated with raised body mass index, inflammatory markers, and in the colorectal and gastro-oesophageal participants compared to breast participants (P < 0.001) independent of other baseline characteristics. Aspirin 100 mg daily decreased U-TXM similarly across all tumour types (median reductions: 77-82%). Aspirin 300 mg daily provided no additional suppression of U-TXM compared with 100 mg.Persistently increased thromboxane biosynthesis was detected after radical cancer therapy, particularly in colorectal and gastro-oesophageal patients. Thromboxane biosynthesis should be explored further as a biomarker of active malignancy and may identify patients likely to benefit from aspirin." @default.
- W4383551209 created "2023-07-08" @default.
- W4383551209 creator A5007286394 @default.
- W4383551209 creator A5007290313 @default.
- W4383551209 creator A5011703751 @default.
- W4383551209 creator A5016107671 @default.
- W4383551209 creator A5022019580 @default.
- W4383551209 creator A5022329395 @default.
- W4383551209 creator A5027645258 @default.
- W4383551209 creator A5029088635 @default.
- W4383551209 creator A5030510055 @default.
- W4383551209 creator A5031415556 @default.
- W4383551209 creator A5033292834 @default.
- W4383551209 creator A5035470085 @default.
- W4383551209 creator A5036665064 @default.
- W4383551209 creator A5036820514 @default.
- W4383551209 creator A5037962146 @default.
- W4383551209 creator A5038226786 @default.
- W4383551209 creator A5040655852 @default.
- W4383551209 creator A5042294700 @default.
- W4383551209 creator A5042398861 @default.
- W4383551209 creator A5047291764 @default.
- W4383551209 creator A5050254542 @default.
- W4383551209 creator A5050794198 @default.
- W4383551209 creator A5051708974 @default.
- W4383551209 creator A5054176875 @default.
- W4383551209 creator A5056008225 @default.
- W4383551209 creator A5056345420 @default.
- W4383551209 creator A5056491116 @default.
- W4383551209 creator A5057207523 @default.
- W4383551209 creator A5059052617 @default.
- W4383551209 creator A5060178886 @default.
- W4383551209 creator A5060595885 @default.
- W4383551209 creator A5069852752 @default.
- W4383551209 creator A5072464958 @default.
- W4383551209 creator A5073507497 @default.
- W4383551209 creator A5073578011 @default.
- W4383551209 creator A5074910871 @default.
- W4383551209 creator A5075059160 @default.
- W4383551209 creator A5076170377 @default.
- W4383551209 creator A5079127159 @default.
- W4383551209 creator A5079788092 @default.
- W4383551209 creator A5080362183 @default.
- W4383551209 creator A5080413634 @default.
- W4383551209 creator A5081747009 @default.
- W4383551209 creator A5085230100 @default.
- W4383551209 creator A5088743450 @default.
- W4383551209 creator A5091347889 @default.
- W4383551209 date "2023-07-07" @default.
- W4383551209 modified "2023-10-15" @default.
- W4383551209 title "Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial" @default.
- W4383551209 cites W108201234 @default.
- W4383551209 cites W1523885354 @default.
- W4383551209 cites W1821541324 @default.
- W4383551209 cites W1900545099 @default.
- W4383551209 cites W1964821535 @default.
- W4383551209 cites W1966562996 @default.
- W4383551209 cites W1971720175 @default.
- W4383551209 cites W1978806425 @default.
- W4383551209 cites W1987837071 @default.
- W4383551209 cites W2011508883 @default.
- W4383551209 cites W2011861566 @default.
- W4383551209 cites W2014644245 @default.
- W4383551209 cites W2020430786 @default.
- W4383551209 cites W2030087792 @default.
- W4383551209 cites W2093666814 @default.
- W4383551209 cites W2110501221 @default.
- W4383551209 cites W2112357684 @default.
- W4383551209 cites W2123587611 @default.
- W4383551209 cites W2125389594 @default.
- W4383551209 cites W2135565955 @default.
- W4383551209 cites W2139355910 @default.
- W4383551209 cites W2151036184 @default.
- W4383551209 cites W2262329766 @default.
- W4383551209 cites W2293189561 @default.
- W4383551209 cites W2321598543 @default.
- W4383551209 cites W2331216347 @default.
- W4383551209 cites W2376159193 @default.
- W4383551209 cites W2385547 @default.
- W4383551209 cites W2539525438 @default.
- W4383551209 cites W2551096297 @default.
- W4383551209 cites W2568572531 @default.
- W4383551209 cites W2571177845 @default.
- W4383551209 cites W2584432485 @default.
- W4383551209 cites W2615058924 @default.
- W4383551209 cites W2619583278 @default.
- W4383551209 cites W2775263281 @default.
- W4383551209 cites W2858639613 @default.
- W4383551209 cites W2897062681 @default.
- W4383551209 cites W2899755710 @default.
- W4383551209 cites W2912331015 @default.
- W4383551209 cites W2922787085 @default.
- W4383551209 cites W2934572398 @default.
- W4383551209 cites W2959920052 @default.
- W4383551209 cites W2970240145 @default.
- W4383551209 cites W2982343288 @default.
- W4383551209 cites W3011609327 @default.
- W4383551209 cites W3014986140 @default.